T
TubeFolio
Back to Dashboard

Did I Call the Bottom With Rivian Stock? | RIVN Stock Analysis

Summary

Parkev analyzes Rivian's recent operational progress, specifically highlighting the R2 model launch which led the company to increase its 2026 sales targets from 60,000 to 70,000 units. Parkev emphasizes the potential of Rivian's upcoming point-to-point autonomous driving technology, suggesting it could become a significant catalyst for high-margin revenue similar to Tesla's software success. Parkev also notes that while macroeconomic headwinds and changes in government incentives have challenged the EV sector, Rivian has managed to grow its trailing twelve-month revenue to over $6.4 billion.

Parkev discusses the company's narrowing losses, with operating margins improving from negative 130% to negative 53%. Parkev believes that as production scales and the more affordable $45,000 R2 model reaches customers, these margins will continue to trend toward profitability. Using a discounted cash flow (DCF) model, Parkev calculates a fair value of $15.50 per share, indicating that the stock is currently undervalued at its $13 market price.

RIVN: Parkev maintains a buy recommendation for Rivian, citing a valuation of $15.50 per share which provides a 16% upside from the current $13 level. Parkev explains that the improvement in operating margins and the success of the R2 model launch are primary drivers for this positive outlook. Parkev acknowledges the stock is high-risk due to expected negative free cash flow for several more years but considers the forward price-to-sales ratio of 1.675 to be attractive.

Mentioned Stocks

RIVN
Sentiment: BUYAction: RECOMMENDED

Reasoning: Parkev reiterates a buy recommendation because Rivian's R2 model launch exceeded expectations, leading to higher sales forecasts for 2026. Parkev notes that operating margins are improving (from -130% to -53%) and strategic partnerships with VW and Uber strengthen the company's roadmap. Based on a DCF analysis, Parkev sets a fair value estimate of $15.50, suggesting a 16% upside from the current price of approximately $13. Parkev views the forward price-to-sales ratio of 1.675 as attractive despite the high-risk nature of the investment.

Loading chart...